Figure 3 Disease progression in ADPKD

Oct 08, 2014

90 likes | 368 Views

Figure 3 Disease progression in ADPKD. Happé, H. and Peters, D. J. M. (2014) Translational research in ADPKD: lessons from animal models Nat. Rev. Nephrol. doi:10.1038/nrneph.2014.137.

Share Presentation

Embed Code

Link

nephrol
animal models
1038 nrneph
doi 10
2014 translational research
figure 3 disease progression

kamal

Download Presentation

Figure 3 Disease progression in ADPKD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Figure 3 Disease progression in ADPKD Happé, H. and Peters, D. J. M. (2014) Translational research in ADPKD: lessons from animal models Nat. Rev. Nephrol. doi:10.1038/nrneph.2014.137

Radiographic Analyses of Disease Progression

Radiographic Analyses of Disease Progression. Vibeke Strand, MD Biopharmaceutical Consultant Clinical Associate Professor Division of Immunology Stanford University School of Medicine. X-ray Analyses of Disease Progression. DMARDs – Leflunomide – Methotrexate – Sulfasalazine

828 views • 43 slides

Figure 3

Figure 3 . Purpose: To further characterize cell-to-cell transmission of α -synuclein using an in vitro coculture model Figure 3(A) Hypothesis:

286 views • 15 slides

Disease Progression in Multiple Sclerosis:

Disease Progression in Multiple Sclerosis: . Case Presentation: Initial Imaging. Assessment of CIS. Devising an Effective Individualized Treatment Plan at the Earliest Stage. Risk of MS After Optic Neuritis. Which DMT in CIS?. Making Treatment Decisions: Considering the Benefits and Risks.

534 views • 32 slides

Polycystic Kidney Disease (ADPKD OR ARPKD)

Polycystic Kidney Disease (ADPKD OR ARPKD). BY: ASHLEY SKOOG. HISTORY. kidney damage seen in PKD is actually the result of the body's immune system Middle age or infancy Polycystic Kidney Disease (PKD), first reported in 1967, is an inherited disease in Persian and Persian-cross cats

905 views • 8 slides

Figure 3

Figure 3.

82 views • 1 slides

Figure 3 Efficacy of treatment beyond progression in four randomized

Figure 3 Efficacy of treatment beyond progression in four randomized phase II or III clinical trials. Kuczynski, E. A. et al. ( 2013) Drug rechallenge and treatment beyond progression—implications for drug resistance Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2013.158.

183 views • 1 slides

Figure #3

Smart Alarm. User Interface. User Interface. Team Members. Original Concept. Recent Progress. Instructor : Prof. Edward Delp, Prof. Jan Allebach. Arrange them in order. Solve the problems. Schedule 4. Schedule 5. 4+(4-3)*(2+1)=? 1+1+1+1+1-1=? (2/3)+3/9-1=?. Schedule 2. Schedule 3.

134 views • 1 slides

Figure 3

control. ApoA-I M. ApoA-I. Figure 3. a. b.

97 views • 1 slides

Figure 3

Figure 3. Afif El-Khuffash. (2014) 76 , 238-244. doi:10.1038/pr.2014.82.

69 views • 1 slides

Disease Progression RLQ #2

JK Amorosa. Disease Progression RLQ #2. ST mass, appendicolith Appendicitis. Red arrow: appendicolith (calcified) Yellow arrows: acoustic shadowing-the sound is blocked by the calcified appendicolith Asterisks: swollen appendix. 12 f. 13 f. 19 m. 91 f. Dx : Acute appendicitis. amorosa.

287 views • 16 slides

Figure 3

Ub. Ub. Ub. Ub. Ub. TNF a. receptor. cytoplasm. adaptor proteins. IKK kinase complex. a. b. IKK complex. NEMO. I k B. NF- k B. 26S proteasome. Phosphorylation of I k B. Ubiquitination and degradation of I k B. NF- k B. ubiquitin. Ub. nucleus. Gene expression.

129 views • 1 slides

Figure 3

Figure 3. (A) Micronutrient composition of various media. (B) Comparison of biomass production in Allen and Arnon media vs. BG-11 media (without combined nitrogen).

93 views • 1 slides

Figure 3

Figure 3. Anna C. Seale. (2013) 74 , 00-00. doi:10.1038/pr.2013.207.

132 views • 1 slides

Disease Progression Abdomen -all quadrants #3

JK Amorosa. Disease Progression Abdomen -all quadrants #3. Abd-pelvis. Solid organs: liver, spleen, k-s, pancreas, adrenals Bowel, mesentery Retroperitoneum Bladder Free air, fluid. ..itis:. Supine abdominal image. Signs of perforation 1.Air on either side of bowel 2.Air pockets

583 views • 36 slides

Figure 3

B) ROC curve of probability for foot ulceration. A) Best Cox regression model of foot ulceration. Figure 3.

113 views • 1 slides

Progression of Chronic Kidney Disease

Progression of Chronic Kidney Disease. Preparation Options Complications. Manage CRF. Control BP Control glucose stop oral agents! Prevent Hyper PTH Vit D Calcium acetate Phosphate binder Diet Education. Preparation of the Patient. Manage Fluids Dialysis education Access Placement

546 views • 30 slides

Disease Progression in Multiple Sclerosis: Predicting Outcomes

Disease Progression in Multiple Sclerosis: Predicting Outcomes. Learning Objective. Disease Progression vs Suboptimal Treatment Response. How Do We Assess Disease Activity?. Patient Presentation. Patient Presentation (cont). Debra’s 2009 Brain MRI (FLAIR). Debra’s 2009 Cervical Spine MRI.

507 views • 34 slides

Figure 2 Imaging findings from patients with ADPKD and ARPKD

Figure 2 Imaging findings from patients with ADPKD and ARPKD. Kurschat, C. E. et al. (2014) An approach to cystic kidney diseases: the clinician’s view Nat. Rev. Nephrol. doi:10.1038/nrneph.2014.173.

123 views • 1 slides

Disease Progression in Multiple Sclerosis: Progressive MS

Disease Progression in Multiple Sclerosis: Progressive MS. Abbreviations. Abbreviations (cont). References. References (cont). References (cont). References (cont).

508 views • 32 slides

More Related